1991 Osteoclast inhibition: An action of nitric oxide not mediated by cyclic GMP. Proc Natl Acad Sci USA 88:2936–2940. , , , , , , ,
1994 Potentiation of osteoclastic bone resorbing activity by inhibition of nitric oxide synthase. Proc Natl Acad Sci USA 91:3569–3573. , , , , , , , ,
1994 Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption. J Clin Invest 93:1465–1472. , , ,
1995 Bone cell function, regulation, and communication: A role for nitric oxide. J Cell Biochem 57:399–408. , ,
1989 Calcitonin gene-related peptide: Isolation, distribution and receptor binding. Ph.D. thesis, University of London, London, U.K.
1997 Nitric oxide is a regulator of bone remodeling. J Pharm Pharmacol 49:897–902. , , , , , , ,
1996 Nitric oxide donor alleviates ovariectomy-induced bone loss. Bone 18:301–304. , , ,
1997 Prevention of corticosteroid-induced bone loss with nitric oxide donor nitroglycerin in male rats. Bone 21:275–280. , , , ,
1995 Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms. Proc Natl Acad Sci USA 92:2954–2958. , , , , , , ,
1993 Nitric oxide stimulates mineralization in osteoblastic cell cultures. J Bone Miner Res 8:S372. , , ,
2000 Frequency-dependent effect of nitric oxide donor, nitroglycerin on bone. J Bone Miner Res 15:1119–1125. , , , , ,
1994 Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 135:330–336. , , , ,
1995 Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity. Endocrinology 136:5445–5453. , , , , , , ,
1995 Nitric oxide: A cytokine-induced regulator of bone resorption. J Bone Miner Res 10:1040–1049. , , , , ,
1996 Nitric oxide is an early mediator of the increase in bone formation by mechanical stimulation. Am J Physiol 270:E955–E960. , ,
1996 Nitric oxide inhibitor L-NAME suppresses mechanically induced bone formation in rats. Am J Physiol 270:E634–E639. , , ,
2000 Restortation of ovariectomy-induced osteopenia by nitroglycerin. Calcif Tissue Int 66:56–60.
Conference report 1993 Consensus Development Conference: Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94:646–650.
1988 Rates of bone loss in normal women: Evidence of accelerated trabecular bone loss after the menopause. Eur J Clin Invest 18:529–534. ,
1973 Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther 184:709–715. ,
1998 Nitrate therapy for stable angina pectoris. N Engl J Med 338:520–531. ,
1998 Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: A randomized placebo-controlled trial. J Clin Endocrinol Metab 83:3817–3825. , , , , , , , , , ,
1998 Biochemical markers of bone turnover—a look at laboratory tests that reflect bone status. Postgrad Med 104:101–112. ,
1992 The prevention and treatment of osteoporosis. N Engl J Med 327:620–627. ,
1994 Osteoporosis: Monitoring techniques and alternative therapies. Calcitonin, fluoride, biphosphonates, vitamin D. Obstet Gynecol Clin North Am 21:321–35.
RonaldA (ed.) 1999 Physicians desk reference (PDR). Nitric oxide and nitroglycerin. United States Department of Health.
1990 Estrogen in prevention and treatment of osteoporosis. Ann NY Acad Sci 592:326–345. ,
1998 Decreased nitric oxide levels and bone turnover in amenorrheic athletes with spinal osteopenia. J Clin Endocrinol Metab 83:3056–3061. , , , ,
1995 Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate. Hypertension 25:848–853. , , , ,
1994 Circulating nitrite/nitrate levels increases with follicular development: Indirect evidence for estradiol-mediated NO release. Biochem Biophys Res Commun 202:1543–1552. , , , ,